80%) did not differ between groups (P = .435). Compliance in the therapy groups was high. All three programs proved feasible, suggesting they may be safely implemented for people with PD in community-based clinical practice." />
Display options
Share it on

Parkinsons Dis. 2012;2012:795294. doi: 10.1155/2012/795294. Epub 2011 Dec 10.

Feasibility, safety, and compliance in a randomized controlled trial of physical therapy for Parkinson's disease.

Parkinson's disease

Jennifer L McGinley, Clarissa Martin, Frances E Huxham, Hylton B Menz, Mary Danoudis, Anna T Murphy, Jennifer J Watts, Robert Iansek, Meg E Morris

Affiliations

  1. Melbourne School of Health Sciences, Physiotherapy, The University of Melbourne, Carlton, VIC 3010, Australia.

PMID: 22191076 PMCID: PMC3236432 DOI: 10.1155/2012/795294

Abstract

Both efficacy and clinical feasibility deserve consideration in translation of research outcomes. This study evaluated the feasibility of rehabilitation programs within the context of a large randomized controlled trial of physical therapy. Ambulant participants with Parkinson's disease (PD) (n = 210) were randomized into three groups: (1) progressive strength training (PST); (2) movement strategy training (MST); or (3) control ("life skills"). PST and MST included fall prevention education. Feasibility was evaluated in terms of safety, retention, adherence, and compliance measures. Time to first fall during the intervention phase did not differ across groups, and adverse effects were minimal. Retention was high; only eight participants withdrew during or after the intervention phase. Strong adherence (attendance >80%) did not differ between groups (P = .435). Compliance in the therapy groups was high. All three programs proved feasible, suggesting they may be safely implemented for people with PD in community-based clinical practice.

References

  1. Neurology. 2010 Jul 13;75(2):116-24 - PubMed
  2. Mov Disord. 2009 Jan 15;24(1):64-71 - PubMed
  3. JAMA. 1997 Jan 1;277(1):25-31 - PubMed
  4. J Neurol Neurosurg Psychiatry. 2003 Feb;74(2):158-62 - PubMed
  5. J Neurol Neurosurg Psychiatry. 2007 Feb;78(2):134-40 - PubMed
  6. Phys Ther. 2000 Jun;80(6):578-97 - PubMed
  7. Mov Disord. 2010 Jul 15;25(9):1217-25 - PubMed
  8. Phys Ther. 2010 Feb;90(2):280-8 - PubMed
  9. Mov Disord. 2010 Jan 30;25(2):194-204 - PubMed
  10. Arch Phys Med Rehabil. 2006 Sep;87(9):1280-2 - PubMed
  11. Mov Disord. 2009 Jan 15;24(1):1-14 - PubMed
  12. Med Sci Sports Exerc. 2002 Feb;34(2):364-80 - PubMed
  13. Neurology. 1967 May;17(5):427-42 - PubMed
  14. J Sci Med Sport. 2006 Oct;9(5):402-12 - PubMed
  15. BMC Geriatr. 2008 Sep 30;8:23 - PubMed
  16. Osteoporos Int. 2007 Apr;18(4):419-25 - PubMed
  17. Med Sci Sports Exerc. 1991 Oct;23(10):1194-200 - PubMed
  18. J Am Geriatr Soc. 1998 Oct;46(10):1207-16 - PubMed
  19. J Am Geriatr Soc. 2003 Dec;51(12):1685-92 - PubMed
  20. Arch Phys Med Rehabil. 2005 Apr;86(4):626-32 - PubMed
  21. Disabil Rehabil. 2008;30(18):1350-7 - PubMed
  22. BMC Neurol. 2011 Jul 31;11:93 - PubMed
  23. Phys Ther. 2006 Oct;86(10):1426-35 - PubMed
  24. J Neurol Neurosurg Psychiatry. 2007 Jul;78(7):678-84 - PubMed
  25. Parkinsonism Relat Disord. 2009 Dec;15(10):752-7 - PubMed
  26. Mov Disord. 2007 Mar 15;22(4):451-60; quiz 600 - PubMed
  27. Clin Rehabil. 2004 Aug;18(5):463-82 - PubMed
  28. Clin Rehabil. 2002 Nov;16(7):717-25 - PubMed
  29. NeuroRehabilitation. 2010;26(4):375-83 - PubMed
  30. Lancet. 2002 Mar 2;359(9308):781-5 - PubMed
  31. Diabetologia. 2008 May;51(5):736-46 - PubMed
  32. Mov Disord. 2006 Apr;21(4):543-8 - PubMed
  33. J Strength Cond Res. 2001 Feb;15(1):109-15 - PubMed
  34. Mov Disord. 2008 Apr 15;23(5):631-40 - PubMed

Publication Types